XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
Recruiting at 21 trial locations
SL
Overseen BySarah Lowe
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: XVIVO Perfusion
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Research Team
JT
Jaya Tiwari
Principal Investigator
XVIVO Perfusion
Eligibility Criteria
Inclusion Criteria
Signed informed consent form (ICF).
You have been registered for a heart transplant.
You are the recipient.
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Treatment
Preservation of hearts for transplant using the XVIVO Heart Preservation System (XHPS)
Immediate pre-transplant period
Follow-up
Participants are monitored for safety and effectiveness after treatment
365 days
Treatment Details
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Subjects requiring a Heart TransplantExperimental Treatment1 Intervention
Device: Preservation of hearts for transplant.
Find a Clinic Near You
Who Is Running the Clinical Trial?
XVIVO Perfusion
Lead Sponsor
Trials
11
Recruited
1,200+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.